Stocktoria
Merck KGaA MRK.DE
DE · Deutsche Börse Xetra · XETR · stock · Healthcare · website
Merck KGaA financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | €21.1B | €21.2B | €21.0B | €22.2B |
| Gross profit | €12.3B | €12.5B | €12.4B | €13.7B |
| R&D expense | €2.4B | €2.3B | €2.4B | €2.5B |
| SG&A expense | €5.5B | €5.4B | €5.3B | €5.4B |
| Operating income | €3.7B | €4.0B | €3.6B | €4.8B |
| Interest expense | €386.0M | €292.0M | €321.0M | €235.0M |
| Income tax | €693.0M | €751.0M | €650.0M | €948.0M |
| Net income | €2.6B | €2.8B | €2.8B | €3.3B |
| EPS (diluted) | €6.00 | €6.39 | €6.49 | €7.65 |
| Operating cash flow | €3.9B | €4.6B | €3.8B | €4.3B |
| Free cash flow | €2.0B | €2.4B | €1.8B | €2.5B |
| Cash & equivalents | €2.3B | €2.1B | €1.6B | €1.4B |
| Inventory | €4.6B | €4.5B | €4.6B | €4.6B |
| Goodwill | €17.9B | €19.1B | €17.8B | €18.4B |
| Total assets | €51.5B | €51.6B | €48.5B | €48.5B |
| Total debt | €12.0B | €10.3B | €9.9B | €10.4B |
| Total liabilities | €22.9B | €21.6B | €21.7B | €22.5B |
| Shareholders' equity | €28.6B | €29.9B | €26.7B | €25.9B |
Growth · year-over-year · Revenue CAGR -1.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | -0.3% | +0.8% | -5.6% | — |
| Net income growth | -6.1% | -1.7% | -15.1% | — |
| EPS growth | -6.1% | -1.5% | -15.2% | — |
| Free cash flow growth | -17.8% | +36.4% | -28.2% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · DE · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.